ARCS Weekly Wrap 20 March 2026
from Cognitio Hosted by LifeSciences Australia
Three signals this week point to a sector at a turning point. Australia’s life sciences industry is accelerating—with stronger local capability, growing global engagement, and a more coordinated national R&D strategy taking shape. But there’s a critical question we need to address. As we move toward a more economically driven innovation model, how do we ensure health and medical research remains grounded in patient outcomes—not just commercial return? In this week’s Top 3, I cover: • The Ambitious Australia R&D strategy—and what it means for our sector • A major capability investment in clinical trials infrastructure here in Sydney • Why international partnerships will define our next phase of growth If we get the balance right, we have a real opportunity to strengthen both our sector and outcomes for patients.
Embed this episode
No transcript yet.